Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02289989 · ClinicalTrials.gov registry record · NA
Oregano Ointment vs. Standard Treatment for Pediatric Atopic Dermatitis
A NA study, sponsored by Rutgers, The State University of New Jersey.
- Terminated
- Registry status
- NA
- Development phase
- 1
- Enrollment target
NCT02289989: Clinical Trial NA study, sponsored by Rutgers, The State University of New Jersey.
NCT02289989 is a NA study that was terminated before completion, run by Rutgers, The State University of New Jersey. The registered enrollment target is 1 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02289989, a NA study, was terminated before completion, sponsored by Rutgers, The State University of New Jersey.
- TERMINATED
- Registry status
- NA
- Development phase
- 1 participants
- Enrollment target
Study Summary
This study is designed to evaluate and compare the efficacy of 3% oregano extract ointment prepared in aqueous solution versus 1% hydrocortisone ointment, a standard treatment, in decreasing the inflammation associated with mild to moderate atopic dermatitis. We plan to recruit 40 patients on the ages comprised between 2 and 17 years old and the study duration for each of the patient is 1 month.
Primary Outcome
This was measured with two questions. The first one referred to the description of the lesion and it included six characteristics: clear, dry, scaly, redness, cracks/opening and oozing. The second questions asked to grade how itchy was the patient. All characteristics were measured on a scale from 0 to 5 (0 none, 5 extremely bothered/losing sleep).
Interventions
- DRUG Hydrocortisone
- DRUG Oregano extract cream
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2014-11 |
| Est. Completion | 2017-01 |
| Phase | NA |
Why NCT02289989 stopped before completion
NCT02289989 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 1 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 2 interventions - of which Hydrocortisone is the first listed.
NCT02289989 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02289989 about?
NCT02289989 is a clinical study titled "Oregano Ointment vs. Standard Treatment for Pediatric Atopic Dermatitis". This study is designed to evaluate and compare the efficacy of 3% oregano extract ointment prepared in aqueous solution versus 1% hydrocortisone ointment, a standard treatment, in decreasing the inflammation associated with mild to moderate atopic dermatitis. We plan to recruit 40 patients on the ag...
What is the current status of trial NCT02289989?
This trial is currently terminated. It is a NA study. The enrollment target is 1 participants. The study started on 2014-11. Estimated completion is 2017-01.
What interventions are being tested in trial NCT02289989?
The interventions under investigation include: Hydrocortisone (DRUG), Oregano extract cream (DRUG).
Who is sponsoring clinical trial NCT02289989?
This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02289989's enrollment target sits among peer trials
1 2001st of 2000 the lowest of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia